These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 26810322

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Preoperative Thrombocytosis in Patients Undergoing Radical Cystectomy for Urothelial Cancer of the Bladder: An Independent Prognostic Parameter for an Impaired Oncological Outcome.
    Jokisch JF, Grimm T, Buchner A, Kretschmer A, Weinhold P, Stief CG, Karl A, Schulz GB.
    Urol Int; 2020; 104(1-2):36-41. PubMed ID: 31242481
    [Abstract] [Full Text] [Related]

  • 26. Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens.
    Cai T, Tiscione D, Verze P, Pomara G, Racioppi M, Nesi G, Barbareschi M, Brausi M, Gacci M, Luciani LG, Liguori G, Gontero P, Campodonico F, Simonato A, Boddi V, Di Stasi SM, Colombo R, Serretta V, Carmignani G, Malossini G, Altieri V, Carini M, Terrone C, Bassi P, Montorsi F, Ficarra V, Selli C, Mirone V, Bartoletti R.
    Urology; 2014 Nov; 84(5):1141-6. PubMed ID: 25239253
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
    Shariat SF, Bolenz C, Godoy G, Fradet Y, Ashfaq R, Karakiewicz PI, Isbarn H, Jeldres C, Rigaud J, Sagalowsky AI, Lotan Y.
    J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
    [Abstract] [Full Text] [Related]

  • 30. Oncologic Outcomes of Robot-Assisted Radical Cystectomy: Results of a High-Volume Robotic Center.
    Gandaglia G, De Groote R, Geurts N, D'Hondt F, Montorsi F, Novara G, Mottrie A.
    J Endourol; 2016 Jan; 30(1):75-82. PubMed ID: 26401724
    [Abstract] [Full Text] [Related]

  • 31. Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy.
    Moschini M, Sharma V, Dell'oglio P, Cucchiara V, Gandaglia G, Cantiello F, Zattoni F, Pellucchi F, Briganti A, Damiano R, Montorsi F, Salonia A, Colombo R.
    BJU Int; 2016 Apr; 117(4):604-10. PubMed ID: 25851271
    [Abstract] [Full Text] [Related]

  • 32. Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study.
    Grimm T, Buchner A, Schneevoigt B, Kretschmer A, Apfelbeck M, Grabbert M, Jokisch JF, Stief CG, Karl A.
    World J Urol; 2016 May; 34(5):703-8. PubMed ID: 26376992
    [Abstract] [Full Text] [Related]

  • 33. Restrictive transfusion in radical cystectomy is safe.
    Syan-Bhanvadia S, Drangsholt S, Shah S, Cai J, Miranda G, Djaladat H, Daneshmand S.
    Urol Oncol; 2017 Aug; 35(8):528.e15-528.e21. PubMed ID: 28476526
    [Abstract] [Full Text] [Related]

  • 34. Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy.
    Abdi H, Pourmalek F, Gleave ME, So AI, Black PC.
    World J Urol; 2016 Jan; 34(1):41-8. PubMed ID: 26621208
    [Abstract] [Full Text] [Related]

  • 35. Late Recurrence of Bladder Cancer following Radical Cystectomy: Characteristics and Outcomes.
    Yoo SH, Kim H, Kwak C, Kim HH, Jung JH, Ku JH.
    Urol Int; 2019 Jan; 103(3):291-296. PubMed ID: 31461728
    [Abstract] [Full Text] [Related]

  • 36. Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical Cystectomy.
    Schuettfort VM, Pradere B, D'Andrea D, Grossmann NC, Quhal F, Mostafaei H, Laukhtina E, Mori K, Rink M, Karakiewicz PI, Motlagh RS, Katayama S, Lotan Y, Scherr D, Abufaraj M, Fajkovica H, Compérat E, Enikeev D, Shariat SF.
    J Urol; 2021 Nov; 206(5):1122-1131. PubMed ID: 34181469
    [Abstract] [Full Text] [Related]

  • 37. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study.
    Vetterlein MW, Gild P, Kluth LA, Seisen T, Gierth M, Fritsche HM, Burger M, Protzel C, Hakenberg OW, von Landenberg N, Roghmann F, Noldus J, Nuhn P, Pycha A, Rink M, Chun FK, May M, Fisch M, Aziz A, PROMETRICS 2011 Study Group.
    BJU Int; 2018 Jan; 121(1):101-110. PubMed ID: 28905486
    [Abstract] [Full Text] [Related]

  • 38. Performance status as a significant prognostic predictor in patients with urothelial carcinoma of the bladder who underwent radical cystectomy.
    Hinata N, Miyake H, Miyazaki A, Nishikawa M, Tei H, Fujisawa M.
    Int J Urol; 2015 Aug; 22(8):742-6. PubMed ID: 25988857
    [Abstract] [Full Text] [Related]

  • 39. How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder.
    Palumbo C, Mistretta FA, Knipper S, Pecoraro A, Tian Z, Shariat SF, Saad F, Simeone C, Briganti A, Antonelli A, Karakiewicz PI.
    Urol Oncol; 2019 Dec; 37(12):893-899. PubMed ID: 31296422
    [Abstract] [Full Text] [Related]

  • 40. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.
    Stein JP, Penson DF, Lee C, Cai J, Miranda G, Skinner DG.
    J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.